The Pre-Participation Evaluation

The pre-participation evaluation exists chiefly to identify conditions that raise the risk of a catastrophic event during exercise, and the dominant concern in young athletes is sudden cardiac death (SCD) from inherited or structural heart conditions. The difficulty is that some important cardiac conditions may be asymptomatic, because a conditioned athlete may have no symptoms, so the evaluation is a screening process looking for hidden risk rather than a response to complaints. Its goal is to reduce risk and to guide safe participation, not simply to disqualify athletes, and the great majority are cleared to play.

The evaluation is broader than the heart. A musculoskeletal review covers previous injuries, incompletely rehabilitated problems, and joint stability, which help identify unresolved symptoms, rehabilitation needs and sport-specific functional limitations to address before the season, recognising that routine screening tests predict future injury only weakly. A general health review covers asthma and exercise-induced bronchoconstriction, a history of concussion, mental health, medication and allergies, and immunisation status. In some sports and settings the evaluation also documents baseline measures and emergency information. Structured tools guide the process, including the pre-participation examination monograph, sport-specific frameworks such as the international federation pre-competition medical assessment used in football, and the recommendations of bodies such as the International Olympic Committee. The point throughout is a systematic, consistent assessment rather than an ad hoc check.

The core of the cardiovascular assessment is a personal and family history and a physical examination. The history asks about exertional chest pain, unexplained fainting (syncope), breathlessness out of keeping with fitness, palpitations, and a family history of premature sudden death or inherited cardiac conditions, and the examination includes blood pressure and cardiac auscultation. Standardised questionnaires such as the fourteen-point American Heart Association set or the pre-participation examination monograph help ensure consistency.

The long-running debate is whether to add a resting twelve-lead electrocardiogram (ECG). The American Heart Association (AHA) recommends a history and physical examination and does not mandate a routine ECG, citing concerns about false-positive results, cost and the logistics of screening large populations. The European Society of Cardiology (ESC), and many international sports governing bodies, recommend adding a resting twelve-lead ECG, because history and examination alone have low sensitivity for the silent conditions that cause sudden cardiac death, and an ECG detects many of them. The crucial skill is interpretation: an athlete's heart shows physiological changes that can mimic disease, so any ECG is read with the International Criteria for electrocardiographic interpretation in athletes, which evolved from the earlier Seattle criteria and sort findings into normal, borderline and abnormal, substantially reducing the false-positive rate. A single borderline finding in an asymptomatic athlete with no concerning history does not usually require investigation, whereas two or more borderline findings, or any abnormal finding, warrant further assessment. More recent guidance frames the electrocardiogram as reasonable where expert interpretation and equitable follow-up resources are available, so whether one is added depends on the programme, the population and the resources rather than being a simple yes or no. In UK elite and professional sport, electrocardiogram-inclusive screening interpreted with these criteria is common.

The value of screening lies in what happens after it. A normal history, examination and, where used, ECG usually lead to clearance to play. Borderline or abnormal findings, or a concerning history, prompt further evaluation before a decision, with the investigation guided by the specific finding and potentially including a repeat electrocardiogram, echocardiography, ambulatory monitoring, exercise testing, cardiac magnetic resonance imaging or genetic assessment. While an athlete is waiting for a diagnosis, temporary restriction from high-intensity or competitive sport depends on the suspected diagnosis and the immediate risk, and may be appropriate if the findings raise a genuine concern, balanced against the burden of unnecessary restriction, so a stratified, individualised approach with longitudinal review is used rather than a blanket ban.

The outcome of the whole evaluation is best thought of as a decision about safe participation: clearance, clearance with conditions or a management plan, further investigation, or, occasionally, restriction from certain activities. Musculoskeletal findings feed into a prehabilitation or rehabilitation plan, and general health issues such as poorly controlled asthma or unaddressed concussion symptoms are managed before return. Throughout, decisions are shared with the athlete and, where relevant, their family and team, and are documented clearly. It is also important to be honest about the limits of screening: no evaluation detects every risk or prevents every event, so emergency planning, including access to a defibrillator and a rehearsed response to sudden cardiac arrest, remains essential alongside the evaluation itself.

• •The main purpose of the pre-participation evaluation is to detect conditions associated with sudden cardiac death, which may be asymptomatic in a fit athlete, not to disqualify athletes.
• •The core cardiovascular assessment is a personal and family history plus a physical examination; standardised questionnaires improve consistency.
• •The American Heart Association uses history and examination and does not mandate a routine electrocardiogram (citing false positives, cost and logistics); the European Society of Cardiology and many sports bodies add a resting twelve-lead electrocardiogram; whether an electrocardiogram is added is increasingly seen as programme, population and resource dependent.
• •History and examination alone have low sensitivity for the silent causes of sudden cardiac death, which is the argument for adding an electrocardiogram.
• •Any electrocardiogram is interpreted with the International Criteria for athletes (evolved from the Seattle criteria), sorting findings into normal, borderline and abnormal to reduce false positives; any abnormal finding, or two or more borderline findings, prompt further evaluation such as echocardiography and specialist assessment.
• •Screening does not detect every risk, so emergency planning with a defibrillator and a rehearsed response to sudden cardiac arrest remains essential.